Acute and Chronic Heart Failure: Clinical Updates and Perspectives—2nd Edition
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Cardiovascular Medicine".
Deadline for manuscript submissions: 20 January 2027 | Viewed by 2300
Editors
Interests: heart failure; cardiogenic shock; ischemic heart disease; percutaneous coronary interventions; structural heart dis-ease; percutaneous ventricular assist devices
Special Issues, Collections and Topics in MDPI journals
Interests: transcatheter aortic valve implantation; percutaneous coronary interventions; heart failure
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
It is my pleasure to invite you to contribute to this Special Issue entitled “Acute and Chronic Heart Failure: Clinical Updates and Perspectives—2nd Edition”. In our previous Special Issue, entitled “Acute and Chronic Heart Failure: Clinical Updates and Perspectives”, we published high-quality original research articles and review papers covering a wide range of topics. This second edition represents the continuation of this series.
Heart failure (HF) represents a twenty-first century cardiovascular epidemic, with over 25 million cases worldwide. The increase in HF cases is partly ascribable to the "paradoxical" advancement of treatments for cardiovascular diseases, with a consequent reduction in mortality and higher incidence of cardiac dysfunction among survivors, partly due to the increase in the longevity of the general population. The prognosis of patients with HF remains poor, with one in nine patients dying one year after diagnosis and about one half dying within five years; moreover, despite appropriate medical treatment, many patients face frequent hospitalization and a reduced quality of life. Furthermore, even when symptoms are controlled, subclinical disease progression can occur due to the underlying neurohormonal imbalance.
In recent decades, several advancements have been made in HF treatment. Pharmacological therapy, alongside well-established therapies, has seen the introduction of new molecules. These molecules have now largely entered clinical practice and are recognized in international guidelines, such as valsartan/sacubitril, SGLT2 inhibitors, and more recent drugs such as vericiguat. Furthermore, device-based therapy has seen a significant improvement, with the development of more efficient systems of cardiac pacing and resynchronization therapy, as well as the production of continuously more efficient and less invasive percutaneous assist devices to improve outcomes and enable survival, even in the patients with the most critical conditions.
Despite these advancements, the prognosis and quality of life for patients with HF often remain poor, and there is an urgent need for further studies. Therefore, the aim of this Special Issue is to provide insights into the latest advancements in all aspects of heart failure treatment in both acute and chronic settings. In particular, original research articles and valuable reviews concerning the newest progress in HF are welcome.
Dr. Luigi Cappannoli
Dr. Cristina Aurigemma
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- acute heart failure
- chronic heart failure
- devices
- drug therapy
- percutaneous ventricular assist devices
- cardiogenic shock
- arrhythmias
- ischemic heart disease
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
